在心血管系统中,乌比基特异蛋白酶的新兴作用
Bipradas Roy1, Preston C Nibley1, Richard Jiang1
1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Molecular pharmacology
|December 19, 2025
概括
脱基因酶 (DUBs) 是一种能抵消无处不在的酶. 新兴研究表明,DUBs可以预防动脉样硬化和心力衰竭等心血管疾病,这表明DUB调节器是潜在的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 乌比基化是一种关键的翻译后修改,它调节了蛋白质的命运,包括降解.
- 脱基因酶 (DUB) 是一种酶,可以去除泛素标签,从而平衡泛化.
- 虽然DUBs已知在神经元发育和癌症中的作用,但它们的心血管功能是新发现的.
研究的目的:
- 审查在心脏和血管系统中选择二维基因酶 (DUB) 的关键作用.
- 突出DUB作为心血管疾病治疗点的潜力.
主要方法:
- 关于二维基因酶 (DUB) 和心血管功能研究的文献综述.
- 在动脉样硬化和心力衰竭模型中分析DUB的作用.
主要成果:
- 脱基酶 (DUBs) 在血管光滑肌肉,内皮和巨细胞中具有保护性,抗炎作用.
- 在小鼠模型中,DUBs减轻了病态心脏重塑.
- 有证据表明,DUB可以减轻动脉样硬化和心脏功能障碍.
结论:
- 脱基酶 (DUB) 调制为心血管疾病提供了一个有前途的治疗策略.
- 针对DUBs可以降低死亡率并改善动脉样硬化和心力衰竭患者的生活质量.
相关概念视频
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
Regulation of the Cardiovascular System
3.6K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.6K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K


